Spore.Bio Revolutionizes Microbiological Testing with AI-Powered, 10-Minute Sample Analysis

October 3, 2026
Spore.Bio Revolutionizes Microbiological Testing with AI-Powered, 10-Minute Sample Analysis
  • Spore.Bio fuses biology, imaging, and artificial intelligence to analyze samples in about 10 minutes with the Louis connected device, slashing the time from days required by conventional culture tests.

  • Louis uses multi‑source lighting and AI to detect, count, and identify bacteria, yeasts, and moulds, removing traditional culture steps and chemical staining from the workflow.

  • The company offers a digital platform that centralizes data for real‑time monitoring across multiple production sites, enabling rapid detection of irregularities and strengthening reactive quality control.

  • Spore.Bio reframes microbiological surveillance as a proactive, automated quality‑management system rather than a delayed, reactive process.

  • Amine Raji co‑founded Spore.Bio in 2023 with Maxime Mistretta and Mohamed Tazi to modernize microbiological monitoring across food, pharmaceutical, cosmetics, and environmental services.

  • Raji brings industrial experience from Nestlé (2017–2022) in maintenance and project engineering, informing his approach to production challenges and performance.

  • Beyond Spore.Bio, Raji is a partner at No Label Ventures, investing in early‑stage deeptech and AI startups, including Uncovr and Davis AI.

Summary based on 1 source


Get a daily email with more AI stories

More Stories